Healthcare / Health Information ServicesUpdated 2026-05-10 22:07 UTC

GDRX stock hub

GoodRx Holdings, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

GDRXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

988.9M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

GDRX

In the news

Latest news · GDRX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E27.8

P25 12.3P50 18.4P75 33.1

Trailing P/E49.2

P25 14.9P50 23.2P75 38.5

ROE3.2

P25 -105.6P50 -46.5P75 -3.1

ROIC4.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All GDRX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

248

Groups with data

Currency

USD

Showing 248 of 248 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001809519
Company name	GoodRx Holdings, Inc.
Country	United States
Country code	US
Cusip	38246G108
Employees	697
Employees Change	-41%
Employees Change Percent	-5.56
Enterprise value	$1.3B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Health Information Services
IPO Date	2020-09-23
Isin	US38246G1085
Last refreshed	2026-05-10
Market cap	$988.9M
Market cap category	Small-Cap
Price	$2.92
Price currency	USD
Rev Per Employee	1,130,400.29x
Sector	Healthcare
Sic	7374
Symbol	GDRX
Website	https://www.goodrx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.08%
EV Earnings	62.98x
EV Sales Forward	1.64x
EV/EBIT	13.37x
EV/EBITDA	11.37x
EV/FCF	7.81x
EV/Sales	1.64x
FCF yield	16.77%
Forward P/E	27.78x
P/B ratio	1.58x
P/E ratio	49.24x
P/S ratio	1.26x
PE Ratio3 Y	83.05x
PS Forward	1.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.29%
EBITDA Margin	14.45%
FCF margin	21.05%
Gross margin	91.83%
Gross Profit	$723.5M
Gross Profit Growth	-3.31%
Gross Profit Growth Q	-8.31%
Gross Profit Growth3 Y	2.2%
Gross Profit Growth5 Y	5.88%
Net Income	$20.6M
Net Income Growth	-27.75%
Net Income Growth Q	-89.42%
Net Income Growth Years	3%
Pretax Margin	5.78%
Profit Margin	2.61%
Profit Per Employee	$29,492
Profitable Years	2
ROA	3.65
Roa5y	2.33
ROCE	8.33
ROE	3.22
Roe5y	-0.33
ROIC	4.79
Roic5y	4.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-22.97%
Cagr3y	-14.05%
Cagr5y	-39.06%
EPS Growth	-17.75
EPS Growth Q	-88.26
EPS Growth Years	3
FCF Growth	10.73%
FCF Growth Q	15.44%
FCF Growth3 Y	4.2%
FCF Growth5 Y	8.82%
OCF Growth	13.01%
OCF Growth Q	25.76%
OCF Growth3 Y	4.57%
OCF Growth5 Y	5.35%
Revenue Growth	-1.19x
Revenue Growth Q	-4.42x
Revenue Growth Years	2x
Revenue Growth3 Y	1.78x
Revenue Growth5 Y	6.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.48
Assets	$2B
Cash	$235.7M
Current Assets	$1.3B
Current Liabilities	$859.2M
Debt	$541.4M
Debt EBITDA	$4.43
Debt Equity	$0.87
Debt FCF	$3.26
Equity	$622M
Interest Coverage	2.32
Liabilities	$1.4B
Long Term Assets	$754.8M
Long Term Liabilities	$540.1M
Net Cash	$-305.6M
Net Cash By Market Cap	$-30.91
Net Debt EBITDA	$2.69
Net Debt Equity	$0.49
Net Debt FCF	$1.84
Tangible Book Value	$-9.7M
Tangible Book Value Per Share	$-0.03
WACC	9.48

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.47
Net Working Capital	$181.5M
Quick ratio	0.55
Working Capital	$407.3M
Working Capital Turnover	$1.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	10.82%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-22.96%
200-day SMA	3.1
3Y total return	-36.52%
50-day SMA	2.24
50-day SMA vs 200-day SMA	50under200
5Y total return	-91.59%
All Time High	64.22
All Time High Change	-95.45%
All Time High Date	2020-09-29
All Time Low	1.77
All Time Low Change	64.97%
All Time Low Date	2026-03-02
ATR	0.14
Beta	1.55
Beta1y	1.02
Beta2y	0.83
Ch YTD	7.75
High	2.94
High52	5.81
High52 Date	2025-10-09
High52ch	-49.74%
Low	2.72
Low52	1.77
Low52 Date	2026-03-02
Low52ch	64.97%
Ma50ch	30.36%
Premarket Change Percent	-1.41
Premarket Price	$2.8
Premarket Volume	2,870
Price vs 200-day SMA	-5.81%
RSI	76.82
RSI Monthly	36.71
RSI Weekly	54.03
Sharpe ratio	-0.05x
Sortino ratio	0.01
Total Return	10.82%
Tr YTD	7.75
Tr1m	42.44%
Tr1w	14.51%
Tr3m	19.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	9
Analyst Count Top	2
Analyst Price Target Top	$3.25
Analyst Ratings	Buy
Analyst Ratings Top	Hold
Earnings EPS Estimate	$0.06
Earnings EPS Estimate Growth	-33.33
Earnings Revenue Estimate	184,112,840x
Earnings Revenue Estimate Growth	-9.29x
Operating Income	$96.8M
Operating Income Growth	8.54
Operating Income Growth Q	-49.59
Operating Income Growth3 Y	46.07
Operating margin	12.29
Price target	$3.66
Price Target Change	$25.34
Price Target Change Top	$11.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	91,437,474%
Float Percent	27%
Net Borrowing	-5,000,000
Shares Insiders	3.99%
Shares Institutions	18.75%
Shares Out	338,675,373
Shares Qo Q	0.19%
Shares Yo Y	-10.82%
Short Float	9.1%
Short Ratio	5.53
Short Shares	2.46

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$91.9M
Average Volume	1,721,345.65x
Bv Per Share	1.84
CAPEX	$-4.5M
Ch1m	42.44
Ch1w	14.51
Ch1y	-22.96
Ch3m	19.67
Ch3y	-36.52
Ch5y	-91.59
Ch6m	-6.11
Change	2.82%
Change From Open	4.29
Close	2.84
Days Gap	-1.41
Depreciation Amortization	16,998,000
Dollar Volume	8,536,211.2
Earnings Date	2026-05-06
Earnings Time	amc
EBIT	$96.8M
EBITDA	$113.8M
EPS	$0.06
F Score	5
FCF	$165.8M
FCF EV Yield	12.81x
FCF Per Share	$0.49
Financing CF	-145,872,000
Fiscal Year End	December
Founded	2,011
Goodwill	430,331,000
Graham Number	1.56788
Graham Upside	-46.31
Income Tax	$25M
Investing CF	-89,728,000
Ipr	-91.15
Iprfo	-93.65
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Ma150	2.71
Ma150ch	7.75%
Ma20	2.41
Ma20ch	21.21%
Net CF	-65,271,000
Next Earnings Date	2026-08-05
Open	2.8
Optionable	Yes
P FCF Ratio	5.96
P OCF Ratio	5.81
Position In Range	90.91
Post Close	2.92
Postmarket Change Percent	-0.02
Postmarket Price	$2.92
Ppne	40,490,000
Pre Close	2.84
Price Date	2026-05-08
Price EBITDA	$8.69
Relative Volume	1.7x
Revenue	787,889,000x
SBC By Revenue	9.39x
Share Based Comp	73,961,000
Tax By Revenue	3.17x
Tax Rate	54.83%
Tr6m	-6.11%
Us State	California
Volume	2,923,360

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does GDRX pay a dividend?

Capital-return profile for this ticker.

Performance

GDRX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns GDRX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+18.8%

Float: +27.0% of shares outstanding

Insider ownership

+4.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

GDRX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

76.8

Above 70: short-term overbought

Price vs 200-day MA

-5.8%

50/200-day relationship not available

Beta (5Y)

1.55

More volatile than the market

Sharpe ratio

-0.05

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About GDRX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current GDRX stock rating?

GoodRx Holdings, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full GDRX analysis?

The full report lives at /stocks/GDRX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for GDRX?

The latest report frames GDRX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the GDRX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.